Halozyme Therapeutics Inc.

(HALO) Trade

By |

Profile

Halozyme Therapeutics Inc is a biopharmaceutical company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

Contact Information

Website: www.halozyme.com
Email: kgustafson@halozyme.com
Main Phone: +1 858 794-8889
Address: 11388 Sorrento Valley Road
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NGS
Employees: 216
NAICS: Biological Produ
$ 16.60 $ -0.08 (-0.48%)
Last Price 16.60 Change $ -0.08 Change % -0.48 Tick N/A
Bid 14.91 Bid Size 100.00 Ask 26.00 Ask Size 200.00
Open 16.60 High 16.77 Low 16.31 Prev Close 16.68
Last Trade Volume 1.2 mi 52 Wk Hi 17.55 52 Wk Low 8.18
Market Cap 2.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 141,915,310.00 EPS (TTM) -0.94 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 54
Number of Buys 17 40
Number of Sells 3 14
Net Activity -524462 419267
Last 10 Buys Shares
Laurie Stelzer 1,000
Kathryn E. Falberg 1,000
Kathryn E. Falberg 1,000
Robert L. Engler 1,000
James P. Shaffer 1,000
Kathryn E. Falberg 1,000
Kenneth J. Kelley 1,000
Gregory I. Frost 1,000
Randal J. Kirk 1,000
Randal J. Kirk 1,000
Last 10 Sell Shares
Kenneth J. Kelley 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Harry J. Leonhardt 1,000
Kenneth J. Kelley 1,000
Robert L. Engler 1,000
Robert L. Engler 1,000
John S. Patton 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 6.75 6.75 6.75 6.75
Mean Target Price Estimate 12.58 12.58 12.58 12.58
Standard Deviation 5.08 5.08 5.08 5.08
Date of Most Recent Estimate 08/10/16 06/10/16 06/10/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.6 1.6 1.6